المؤلفون: Hisashi Tanaka (158467), Shigeru Tanzawa (14280339), Toshihiro Misumi (651895), Tomonori Makiguchi (3585257), Megumi Inaba (6547850), Takeshi Honda (150171), Junya Nakamura (2178982), Koji Inoue (456339), Takayuki Kishikawa (14280342), Masanao Nakashima (14135086), Keiichi Fujiwara (234194), Tadashi Kohyama (673197), Hiroo Ishida (8282772), Shoichi Kuyama (9311677), Naoki Miyazawa (13903234), Tomomi Nakamura (136504), Hiroshi Miyawaki (9556162), Naohiro Oda (6173909), Nobuhisa Ishikawa (224940), Ryotaro Morinaga (14280345), Kei Kusaka (14280348), Nobukazu Fujimoto (81969), Yasushi Fukuda (7109687), Masayuki Yasugi (14280351), Takeshi Tsuda (9978357), Sunao Ushijima (14280354), Kazuhiko Shibata (8614500), Takuo Shibayama (9311674), Akihiro Bessho (14280357), Kyoichi Kaira (9439314), Kenshiro Shiraishi (818624), Noriyuki Matsutani (9588713), Nobuhiko Seki (6064028)

مصطلحات موضوعية: Respiratory Diseases, Oncology and Carcinogenesis not elsewhere classified, Pharmacology and Pharmaceutical Sciences not elsewhere classified, Aged Health Care, cisplatin, chemoradiotherapy, durvalumab, non-small-cell lung cancer, S-1

Relation: https://figshare.com/articles/presentation/sj-pptx-2-tam-10_1177_17588359221142786_Supplemental_material_for_A_phase_II_study_of_S-1_and_cisplatin_with_concurrent_thoracic_radiotherapy_followed_by_durvalumab_for_unresectable_locally_advanced_non-small-cell_lung_cancer_in_Japan_SAMUR/21754029

الاتاحة: https://doi.org/10.25384/sage.21754029.v1

المؤلفون: Hisashi Tanaka (158467), Shigeru Tanzawa (14280339), Toshihiro Misumi (651895), Tomonori Makiguchi (3585257), Megumi Inaba (6547850), Takeshi Honda (150171), Junya Nakamura (2178982), Koji Inoue (456339), Takayuki Kishikawa (14280342), Masanao Nakashima (14135086), Keiichi Fujiwara (234194), Tadashi Kohyama (673197), Hiroo Ishida (8282772), Shoichi Kuyama (9311677), Naoki Miyazawa (13903234), Tomomi Nakamura (136504), Hiroshi Miyawaki (9556162), Naohiro Oda (6173909), Nobuhisa Ishikawa (224940), Ryotaro Morinaga (14280345), Kei Kusaka (14280348), Nobukazu Fujimoto (81969), Yasushi Fukuda (7109687), Masayuki Yasugi (14280351), Takeshi Tsuda (9978357), Sunao Ushijima (14280354), Kazuhiko Shibata (8614500), Takuo Shibayama (9311674), Akihiro Bessho (14280357), Kyoichi Kaira (9439314), Kenshiro Shiraishi (818624), Noriyuki Matsutani (9588713), Nobuhiko Seki (6064028)

مصطلحات موضوعية: Respiratory Diseases, Oncology and Carcinogenesis not elsewhere classified, Pharmacology and Pharmaceutical Sciences not elsewhere classified, Aged Health Care, cisplatin, chemoradiotherapy, durvalumab, non-small-cell lung cancer, S-1

Relation: https://figshare.com/articles/journal_contribution/sj-docx-1-tam-10_1177_17588359221142786_Supplemental_material_for_A_phase_II_study_of_S-1_and_cisplatin_with_concurrent_thoracic_radiotherapy_followed_by_durvalumab_for_unresectable_locally_advanced_non-small-cell_lung_cancer_in_Japan_SAMUR/21754026

الاتاحة: https://doi.org/10.25384/sage.21754026.v1

المؤلفون: Yasuhiko Koga (11472270), Takahiro Satoh (11472273), Kyoichi Kaira (9439314), Yoshimasa Hachisu (11472276), Yasuyuki Ishii (2430634), Toshiki Yajima (11472279), Takeshi Hisada (482810), Hideaki Yokoo (138844), Kunio Dobashi (482816)

مصطلحات موضوعية: Medicine, Molecular Biology, Pharmacology, Biotechnology, Sociology, Virology, Biological Sciences not elsewhere classified, silicate inhalation recently, significantly poorer prognosis, ray emission analysis, rapidly progressive pneumoconiosis, possible risk factor, including smoking history, idiopathic pulmonary fibrosis, forced vital capacity, environmental dust exposure, lung tissue samples, lungs significantly correlated, control lung samples, detecting inhaled elements, control lungs, lung may, inhaled elements, significant differences, significant difference, results indicate, remains unclear, partly involved, multivariate analyses, lungs using

Relation: https://figshare.com/articles/journal_contribution/Progression_of_Idiopathic_Pulmonary_Fibrosis_Is_Associated_with_Silica_Silicate_Inhalation/16670529

الاتاحة: https://doi.org/10.1021/acs.estlett.1c00659.s001

المؤلفون: Atsuto Mouri (7113074), Kyoichi Kaira (9439314), Ou Yamaguchi (10217901), Kosuke Hashimoto (422123), Yu Miura (2515246), Ayako Shiono (4227943), Shun Shinomiya (10302761), Tomoe Akagami (10302764), Hisao Imai (6787583), Kunihiko Kobayashi (345089), Hiroshi Kagamu (412409)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, antinuclear antibodies, immune-check point inhibitor, non-small cell lung cancer, immune-related adverse events, feasibility

Relation: https://figshare.com/articles/figure/Image_1_Efficacy_and_Feasibility_of_Programmed_Death-1_Programmed_Death_Ligand-1_Blockade_Therapy_in_Non-Small_Cell_Lung_Cancer_Patients_With_High_Antinuclear_Antibody_Titers_jpeg/14215184

الاتاحة: https://doi.org/10.3389/fonc.2021.610952.s001

المؤلفون: Atsuto Mouri (7113074), Kyoichi Kaira (9439314), Ou Yamaguchi (10217901), Kosuke Hashimoto (422123), Yu Miura (2515246), Ayako Shiono (4227943), Shun Shinomiya (10302761), Tomoe Akagami (10302764), Hisao Imai (6787583), Kunihiko Kobayashi (345089), Hiroshi Kagamu (412409)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, antinuclear antibodies, immune-check point inhibitor, non-small cell lung cancer, immune-related adverse events, feasibility

Relation: https://figshare.com/articles/figure/Image_3_Efficacy_and_Feasibility_of_Programmed_Death-1_Programmed_Death_Ligand-1_Blockade_Therapy_in_Non-Small_Cell_Lung_Cancer_Patients_With_High_Antinuclear_Antibody_Titers_jpeg/14215190

الاتاحة: https://doi.org/10.3389/fonc.2021.610952.s003

المؤلفون: Atsuto Mouri (7113074), Kyoichi Kaira (9439314), Ou Yamaguchi (10217901), Kosuke Hashimoto (422123), Yu Miura (2515246), Ayako Shiono (4227943), Shun Shinomiya (10302761), Tomoe Akagami (10302764), Hisao Imai (6787583), Kunihiko Kobayashi (345089), Hiroshi Kagamu (412409)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, antinuclear antibodies, immune-check point inhibitor, non-small cell lung cancer, immune-related adverse events, feasibility

Relation: https://figshare.com/articles/figure/Image_4_Efficacy_and_Feasibility_of_Programmed_Death-1_Programmed_Death_Ligand-1_Blockade_Therapy_in_Non-Small_Cell_Lung_Cancer_Patients_With_High_Antinuclear_Antibody_Titers_jpeg/14215193

الاتاحة: https://doi.org/10.3389/fonc.2021.610952.s004

المؤلفون: Atsuto Mouri (7113074), Kyoichi Kaira (9439314), Ou Yamaguchi (10217901), Kosuke Hashimoto (422123), Yu Miura (2515246), Ayako Shiono (4227943), Shun Shinomiya (10302761), Tomoe Akagami (10302764), Hisao Imai (6787583), Kunihiko Kobayashi (345089), Hiroshi Kagamu (412409)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, antinuclear antibodies, immune-check point inhibitor, non-small cell lung cancer, immune-related adverse events, feasibility

Relation: https://figshare.com/articles/figure/Image_2_Efficacy_and_Feasibility_of_Programmed_Death-1_Programmed_Death_Ligand-1_Blockade_Therapy_in_Non-Small_Cell_Lung_Cancer_Patients_With_High_Antinuclear_Antibody_Titers_jpeg/14215187

الاتاحة: https://doi.org/10.3389/fonc.2021.610952.s002